---
title: "eXoZymes Raises $0.64 Million Via Unit Offering; Adds MDB Placement Pact and Warrant Coverage"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291460148.md"
description: "eXoZymes raised $0.64 million via a registered unit offering of 35,555 units at $18.00 each. Proceeds will fund NCT technology development and R&D. The company engaged MDB Capital as placement agent, signed a securities purchase agreement with an investor, and modified its warrant agent agreement with VStock Transfer. New warrants have an $11.24 exercise price, exercisable from June 2027 to June 2031."
datetime: "2026-07-01T20:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291460148.md)
  - [en](https://longbridge.com/en/news/291460148.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291460148.md)
generator: "portal-rs"
---

# eXoZymes Raises $0.64 Million Via Unit Offering; Adds MDB Placement Pact and Warrant Coverage

eXoZymes raised approximately $0.64 million in gross proceeds through a registered offering of 35,555 units at $18.00 per unit, each consisting of one share and one warrant. Net proceeds, after $44,799 in commissions and about $30,000 in expenses, will support NCT technology development, next-in-line products, R&D, and general corporate purposes. The company entered a Placement Agent Agreement with MDB Capital, executed an investor Securities Purchase Agreement, and modified its Warrant Agent Agreement with VStock Transfer to cover the newly issued warrants. The warrants carry a $11.24 exercise price, become exercisable on Jun 5, 2027, and expire on Jun 5, 2031, with a reset feature under specified pre-commencement financings.

**Agreement 1: eXoZymes Raises $0.64 Million in Unit Offering; MDB Capital Acts as Placement Agent**

-   **Agreement type**: Placement Agent Agreement for registered direct unit offering
-   **Counterparty**: MDB Capital
-   **Signed / Effective**: Jun 30 2026 / same
-   **Duration / Termination**: Transaction-specific
-   **Reason**: Raise capital for NCT development and corporate purposes

**Agreement 2: eXoZymes Enters Securities Purchase Agreement for 35,555 Units Priced at $18.00**

-   **Agreement type**: Securities purchase agreement for registered unit offering
-   **Counterparty**: An investor
-   **Signed / Effective**: Jun 30 2026 / same
-   **Duration / Termination**: Transaction-specific
-   **Reason**: Provide equity funding for NCT initiatives and operations

**Agreement 3: eXoZymes Modifies Warrant Agent Pact With VStock Transfer to Cover New Warrants**

-   **Agreement type**: Modification to Warrant Agent Agreement
-   **Counterparty**: VStock Transfer
-   **Signed / Effective**: Jun 30 2026 / same
-   **Duration / Termination**: Through Jun 05 2031
-   **Reason**: Administer warrants issued in the offering

Original SEC Filing: EXOZYMES INC. \[ EXOZ \] - 8-K - Jul. 01, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [EXOZ.US](https://longbridge.com/en/quote/EXOZ.US.md)
- [MDBH.US](https://longbridge.com/en/quote/MDBH.US.md)

## Related News & Research

- [EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization](https://longbridge.com/en/news/296532185.md)
- [Exozymes Raises $5.95 Million in Underwritten Equity Offering Led by MDB Capital](https://longbridge.com/en/news/290107775.md)
- [Guardian Metal Resources PLC Announces Warrant Exercise | GMTL Stock News](https://longbridge.com/en/news/296090846.md)
- [REG - Sareum Holdings PLC - Exercise of Warrants](https://longbridge.com/en/news/296362927.md)
- [ReconAfrica receives $4.97 million from warrant exercises](https://longbridge.com/en/news/296156008.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**